Clinical Trials on Heparin-induced Thrombocytopenia Type II in France
Total 265 results
-
Mitsubishi Tanabe Pharma CorporationCompletedHeparin-induced Thrombocytopenia Type IIFrance
-
Central Hospital, Nancy, FranceRecruitingHeparin-induced ThrombocytopeniaFrance
-
University Hospital, Strasbourg, FranceRecruitingHeparin-induced Thrombocytopenia (HIT)France
-
Centre Hospitalier Universitaire de BesanconCompletedHeparin-induced Thrombocytopenia (HIT)France
-
Centre Hospitalier Universitaire, AmiensRecruitingPlatelet Aggregation | Heparin-induced Thrombocytopenia | Platelet Activation | Platelet DisorderFrance
-
Aspen Global IncorporatedTerminatedHeparin-induced ThrombocytopeniaUnited States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russian Federation, Serbia
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingHeparin-induced ThrombocytopeniaFrance
-
Children's Hospital Los AngelesCompletedThrombosis | Heparin-induced ThrombocytopeniaUnited States
-
Centre Hospitalier Universitaire de Saint EtienneSanofi; Hyphen BioMed; CIC-EC de Saint-Etienne; Groupe d'étude sur l'Hémostase... and other collaboratorsCompletedHeparin-induced ThrombocytopeniaFrance
-
Ramsay Générale de SantéEuropean Clinical Trial Experts NetworkNot yet recruitingChronic Renal Failure | Heparin-induced Thrombocytopenia | Dialysis; ComplicationsFrance
-
Centre Hospitalier Universitaire, AmiensRecruitingHeparin-induced Thrombocytopenia | Platelet Activation | Platelets | Leukocytes | HIT | Platelet/Leukocyte Aggregates | HITSTREAM | Flow CytometryFrance
-
University Hospital, LilleRecruitingComparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease (TargetOH)Liver Diseases | Acute on Chronic Hepatic FailureFrance
-
Hospices Civils de LyonRecruitingHearing LossFrance
-
Centre Hospitalier Universitaire, AmiensMerck Serono International SACompletedRenal Disorder Associated With Type II Diabetes MellitusFrance
-
SensorionRecruitingHearing Loss OtotoxicFrance
-
Direction Centrale du Service de Santé des ArméesCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedDiabetic Nephropathy | Persistent Proteinuria With Type II DiabetesFrance
-
Direction Centrale du Service de Santé des ArméesRecruiting
-
Novartis PharmaceuticalsCompletedThrombocytopaeniaUnited States, Belgium, Canada, Hong Kong, Argentina, Brazil, Czechia, Germany, Greece, Israel, Netherlands, Spain, Thailand, Hungary, Ireland, Italy, Mexico, Taiwan, Korea, Republic of, Poland, Russian Federation, Puerto Rico
-
Boston TherapeuticsWithdrawn
-
Genzyme, a Sanofi CompanyCompletedGlycogenesis 2 Acid Maltase Deficiency | Pompe Disease (Late-Onset) | Glycogen Storage Disease Type II (GSD II)France
-
Assistance Publique - Hôpitaux de ParisCompletedMay-Hemalin | Fechtner Syndrome (Disorder) | Epstein Syndrome (Disorder) | MYH9 Related DisordersFrance
-
Mauna Kea TechnologiesUnknownHepatocarcinoma | Hepatic Tumor | Hepatic MetastasisFrance
-
Hospices Civils de LyonCompleted
-
Centre Hospitalier Universitaire DijonCompleted
-
Centre Hospitalier Sud FrancilienCompleted
-
Lille Catholic UniversityCompletedType II DiabetesFrance
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2France
-
AmgenActive, not recruitingChemotherapy-induced ThrombocytopeniaUnited States, France, Austria, Hungary, Russian Federation, Romania, Spain, Turkey, Greece, Italy, Bulgaria, Canada, Portugal, Argentina, Poland, Mexico, Colombia, Peru, Brazil, Ukraine
-
University Hospital, Clermont-FerrandRecruitingBipolar Disorder Type II | Mood Depressive DisorderFrance
-
Centre Georges Francois LeclercCompleted
-
University Hospital, Strasbourg, FranceCompleted
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Institut de Cancérologie de LorraineRecruitingQuality of Life | Cancer | Hearing Disorders | Ototoxicity, Drug-InducedFrance
-
French Cardiology SocietyTerminatedFamilial HypercholesterolemiaFrance
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
University Hospital, LilleTerminatedGlioblastoma | ThrombocytopeniaFrance
-
Center Eugene MarquisCompleted
-
Arizona State UniversityTakeda Pharmaceuticals North America, Inc.UnknownType II Diabetes MellitusUnited States
-
University Hospital, Clermont-FerrandRecruitingBipolar Disorder Type I or II (According to DSM-5)France
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II) | Acid Maltase DeficiencyUnited States, Belgium, Denmark, France, Germany, Netherlands, United Kingdom
-
University Hospital, Clermont-FerrandRecruitingChemotherapy-induced Peripheral NeuropathyFrance
-
Assistance Publique - Hôpitaux de ParisInstitute of Cardiometabolism and Nutrition, FranceCompletedFamilial Hypercholesterolemia - HeterozygousFrance
-
Assistance Publique - Hôpitaux de ParisGeneral ElectricCompletedHepatocellular CarcinomaFrance
-
Groupe Hospitalier Pitie-SalpetriereCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1France
-
Centre Leon BerardRecruiting
-
AmgenCompletedType II Refractory Celiac Disease (RCD-II) | In-situ Small Bowel T-cell LymphomaSpain, United States, Finland, France, Netherlands
-
Hospices Civils de LyonUnknown
-
University Hospital, MontpellierFederation Francophone de Cancerologie DigestiveRecruitingCholangiocarcinoma Non-resectable | Non-metastaticFrance
-
Oticon MedicalCompletedHearing Loss, Cochlear | Neurinoma of the Acoustic NerveFrance